Real World Efficacy, Tolerability and Safety of Ubrogepant

被引：0
|
作者：
Chiang, Chia-Chun [1 ]
Arca, Karissa
Dunn, Rachel [3 ]
Girardo, Marlene [2 ]
Quillen, Jaxon [2 ]
Dodick, David
Starling, Amaal
机构：
[1] Mayo Clin, Neurol, Rochester, MI USA
[2] Mayo Clin Arizona, Biostat, Phoenix, AZ USA
[3] Mayo Clin Alix Sch Med, Rochester, MI USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2485
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Real world efficacy, tolerability and safety of ubrogepant
    Chiang, C.
    Arca, K. N.
    Dunn, R. B.
    Girardo, M. E.
    Quillen, J. K.
    Dodick, D. W.
    Starling, A. J.
    HEADACHE, 2021, 61 : 139 - 140
  • [2] Real-World Efficacy, Tolerability and Safety of Ubrogepant
    Chiang, C. C.
    Arca, K.
    Dunn, R.
    Girardo, M.
    Quillen, J.
    Dodick, D. W.
    Starling, A.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 142 - 143
  • [3] Real-world efficacy, tolerability, and safety of ubrogepant
    Chiang, Chia-Chun
    Arca, Karissa N.
    Dunn, Rachel B.
    Girardo, Marlene E.
    Quillen, Jaxon K.
    Dodick, David W.
    Starling, Amaal J.
    HEADACHE, 2021, 61 (04): : 620 - 627
  • [4] Real-World Efficacy, Tolerability and Safety of Ubrogepant
    Chiang, C. C.
    Arca, K.
    Dunn, R.
    Girardo, M.
    Quillen, J.
    Dodick, D. W.
    Starling, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 96 - 96
  • [5] A Comprehensive Review of the Mechanism, Efficacy, Safety, and Tolerability of Ubrogepant in the Treatment of Migraine
    Dighriri, Ibrahim M.
    Nazel, Shahad
    Alharthi, Aeshah M.
    Altowairqi, Nasreen A.
    Albariqi, Aqeel M.
    Tohari, Mona A.
    Alameer, Atheer A.
    Alsaran, Amjad K.
    Alshammari, Fares R.
    Almutairi, Naif F.
    Alsubaie, Fahad M.
    Alharbi, Turki A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [6] Efficacy, tolerability and safety of teriflunomide in multiple sclerosis in a real-world clinical setting
    Oreja-Guevara, C.
    Orviz-Garcia, A.
    Guerra-Schulz, E.
    Lopez de Velasco, V.
    Lopez-Perez, F.
    Palacios, M.
    Gonzalez-Suarez, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 544 - 544
  • [7] Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia
    Colbert, Gates
    Sannapaneni, Shilpa
    Lerma, Edgar, V
    DRUG HEALTHCARE AND PATIENT SAFETY, 2022, 14 : 87 - 96
  • [8] Safety an Tolerability of Ubrogepant Following Intermittent, High Frequency Dosing
    Trugman, Joel M.
    Goadsby, Peter J.
    Tepper, Stewart J.
    Watkins, Paul
    Ayele, Girma
    Miceli, Rosa
    Severt, Lawrence
    Finnegan, Michelle
    Szegedi, Armin
    Jakate, Abhijeet
    NEUROLOGY, 2019, 92 (15)
  • [9] Early experiences in adjuvant treatment of melanoma: Real-world data on tolerability, safety and efficacy
    van Laar, S.
    Kapiteijn, E.
    Gombert, K.
    Guchelaar, H-J.
    Zwaveling, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S917 - S917
  • [10] Early Real-World Safety, Tolerability, and Efficacy of Cladribine Tablets: A Single Center Experience
    Bain, Julie
    Jones, Ashley
    Overholt, Sarah
    Guenette, Melanie
    Selchen, Daniel
    Oh, Jiwon
    NEUROLOGY, 2020, 94 (15)
12345